Skip to main content

St. Louis-born Galera's stock soars after release of positive study data for its experimental cancer therapy

The company, which was launched in St. Louis and still has operations here, expects to soon start dosing patients for a midstage study of the new drug candidate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.